Updates | ClinRegs

Malawi Profile Updated in ClinRegs

Aug 18, 2021 - The Malawi profile in ClinRegs has been reviewed and updated with the following information: Legislation and webpages related to the Pharmacy and Medicines Regulatory Authority (PMRA), which has replaced the Pharmacy, Medicines and Poisons Board (PMPB) as of October ...

Guinea Profile Updated in ClinRegs

Aug 13, 2021 - The Guinea profile in ClinRegs has been reviewed and updated with the following information: Updated details on the responsibilities of the National Directorate of Pharmacy and Medicine (Direction Nationale de la Pharmacie et du Médicament) (DNPM) (See Regulatory Authority) Updated ...

Liberia Profile Updated in ClinRegs

Aug 12, 2021 - The Liberia profile in ClinRegs has been reviewed and updated to include the following: Additional information on the responsibilities and activities Liberian Medicines and Health Products Regulatory Authority (LMHRA)’s Pharmacovigilance and Clinical Trials Unit (See Regulatory ...

Canada Profile Updated in ClinRegs

Aug 6, 2021 - The Canada profile in ClinRegs has been reviewed and updated with the following information: Updated Drug Submission Application Form and Qualified Investigator Undertaking Form (See Submission Process, Trial Initiation, and Site/Investigator Selection) New guideline ...

Thailand Profile Updated in ClinRegs

Jul 22, 2021 - The Thailand profile in ClinRegs has been reviewed and updated to reflect all current regulatory requirements. Key updates include: Updated clinical trial drug importation license application submission instructions to the Thai Food and Drug Administration (Thai FDA)’s ...

UK: MHRA Announces Combined Regulatory and Ethics Review Starting in 2022

Jul 20, 2021 - On July 15, 2021, the United Kingdom’s (UK’s) Medicines and Healthcare products Regulatory Agency (MHRA) announced that starting in January 2022, all new Clinical Trials of Investigational Medicinal Products (CTIMPs) will undergo combined review from the MHRA and the UK Research Ethics ...

Uganda: NDA Issues Statement on Conduct of Clinical Trials during COVID-19

Jul 20, 2021 - The Uganda National Drug Authority (NDA) issued a statement on June 28, 2021, to sponsors and principal investigators (PIs) regarding the conduct of clinical trials during the COVID-19 lockdown. The statement notes the following: Clinical trial reviews will continue to be done remotely Researchers ...